SCHEMBL13645544

SCHEMBL13645544

Fc1cc2c3c(cccc3c1)-c1ccccc1-2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
MAPK1 P28482 4/20 0.61
HSD17B10 Q99714 4/20 0.61
TSHR P16473 3/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
ATM Q13315 2/20 0.61
CASP1 P29466 3/20 0.54
HPGD P15428 2/20 0.54
HIF1A Q16665 2/20 0.54
CASP7 P55210 2/20 0.54
TP53 P04637 1/20 0.54
CYP3A4 P08684 1/20 0.48
PABPC1 P11940 1/20 0.48
DNMT1 P26358 1/20 0.48
KLK7 P49862 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2A6 P11509 1/20 0.44
ANPEP P15144 1/20 0.41
CES1 P23141 2/20 0.39
CES2 O00748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16200908 0.80 ALDH1A1 (0.58) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
Fluoranthene SCHEMBL29396242 0.77 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
Fluoranthene SCHEMBL27152 0.77 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
Fluoranthene SCHEMBL29355720 0.77 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
Fluoranthene SCHEMBL8873541 0.77 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
SCHEMBL23525587 0.77 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
SCHEMBL24931449 0.76 ALDH1A1 (0.58) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
SCHEMBL9466398 0.76 ALDH1A1 (0.58) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
SCHEMBL23816647 0.76 ALDH1A1 (0.58) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1
SCHEMBL20982403 0.76 ALDH1A1 (0.58) ALDH1A1MAPK1HSD17B10TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2108690-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed
US-20090153039-A1 Green electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-06-18 US disclosed
EP-2067766-A1 Green electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-06-10 EP disclosed
EP-2067767-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-06-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090153039-A1 Green electroluminescent compounds and organic electroluminescent device using the same C1S, ACSL3, CCNL2 ALDH1A1 715/4885MAPK1 1635/4885HSD17B10 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.